| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T18 |
12-13 |
-COMMA- |
denotes |
, |
| T19 |
14-29 |
NNS |
denotes |
immunoglobulins |
| T20 |
29-30 |
-COMMA- |
denotes |
, |
| T21 |
31-34 |
CC |
denotes |
and |
| T22 |
35-50 |
NNS |
denotes |
corticosteroids |
| T23 |
52-62 |
NNS |
denotes |
Highlights |
| T24 |
63-64 |
IN |
denotes |
• |
| T25 |
66-70 |
NNP |
denotes |
IVIG |
| T26 |
70-71 |
-COMMA- |
denotes |
, |
| T27 |
72-80 |
VBN |
denotes |
combined |
| T28 |
81-85 |
IN |
denotes |
with |
| T29 |
86-99 |
NN |
denotes |
moderate-dose |
| T30 |
100-102 |
IN |
denotes |
of |
| T31 |
103-118 |
NNS |
denotes |
corticosteroids |
| T32 |
118-119 |
-COMMA- |
denotes |
, |
| T33 |
120-125 |
MD |
denotes |
might |
| T34 |
126-133 |
VB |
denotes |
improve |
| T35 |
134-141 |
NN |
denotes |
patient |
| T36 |
142-150 |
NNS |
denotes |
outcomes |
| T37 |
152-153 |
PDT |
denotes |
• |
| T38 |
155-158 |
DT |
denotes |
The |
| T39 |
159-162 |
NN |
denotes |
use |
| T40 |
163-165 |
IN |
denotes |
of |
| T41 |
166-181 |
NNS |
denotes |
corticosteroids |
| T42 |
182-187 |
MD |
denotes |
might |
| T43 |
188-198 |
VB |
denotes |
accelerate |
| T44 |
199-207 |
NN |
denotes |
recovery |
| T45 |
208-212 |
IN |
denotes |
from |
| T46 |
213-221 |
NN |
denotes |
COVID-19 |
| T47 |
223-224 |
PDT |
denotes |
• |
| T48 |
226-228 |
DT |
denotes |
No |
| T49 |
229-239 |
VBN |
denotes |
controlled |
| T50 |
240-248 |
JJ |
denotes |
clinical |
| T51 |
249-255 |
NNS |
denotes |
trials |
| T52 |
256-261 |
VBP |
denotes |
exist |
| T53 |
262-264 |
IN |
denotes |
on |
| R16 |
T19 |
T18 |
arg2Of |
immunoglobulins,"," |
| R17 |
T21 |
T20 |
arg1Of |
and,"," |
| R18 |
T18 |
T21 |
arg1Of |
",",and |
| R19 |
T22 |
T21 |
arg2Of |
corticosteroids,and |
| R20 |
T25 |
T24 |
arg1Of |
IVIG,• |
| R21 |
T25 |
T26 |
arg1Of |
IVIG,"," |
| R22 |
T25 |
T27 |
arg2Of |
IVIG,combined |
| R23 |
T27 |
T28 |
arg1Of |
combined,with |
| R24 |
T29 |
T28 |
arg2Of |
moderate-dose,with |
| R25 |
T29 |
T30 |
arg1Of |
moderate-dose,of |
| R26 |
T31 |
T30 |
arg2Of |
corticosteroids,of |
| R27 |
T34 |
T32 |
arg1Of |
improve,"," |
| R28 |
T25 |
T33 |
arg1Of |
IVIG,might |
| R29 |
T34 |
T33 |
arg2Of |
improve,might |
| R30 |
T25 |
T34 |
arg1Of |
IVIG,improve |
| R31 |
T36 |
T34 |
arg2Of |
outcomes,improve |
| R32 |
T36 |
T35 |
arg1Of |
outcomes,patient |
| R33 |
T39 |
T37 |
arg1Of |
use,• |
| R34 |
T39 |
T38 |
arg1Of |
use,The |
| R35 |
T39 |
T40 |
arg1Of |
use,of |
| R36 |
T41 |
T40 |
arg2Of |
corticosteroids,of |
| R37 |
T39 |
T42 |
arg1Of |
use,might |
| R38 |
T43 |
T42 |
arg2Of |
accelerate,might |
| R39 |
T39 |
T43 |
arg1Of |
use,accelerate |
| R40 |
T44 |
T43 |
arg2Of |
recovery,accelerate |
| R41 |
T44 |
T45 |
arg1Of |
recovery,from |
| R42 |
T46 |
T45 |
arg2Of |
COVID-19,from |
| R43 |
T51 |
T47 |
arg1Of |
trials,• |
| R44 |
T51 |
T48 |
arg1Of |
trials,No |
| R45 |
T51 |
T49 |
arg2Of |
trials,controlled |
| R46 |
T51 |
T50 |
arg1Of |
trials,clinical |
| R47 |
T51 |
T52 |
arg1Of |
trials,exist |
| R48 |
T52 |
T53 |
arg1Of |
exist,on |